ANIK
Anika Therapeutics, Inc.$14.78+0.06 (+0.41%)Prev Close$14.72·MCap$215.7M·P/E—·Vol32.5K·Yield—
▲
Buys (12M)
2
$223.2K
▼
Sells (12M)
0
$0.00
◆
Net Activity
Net Buyer
$223.2K
●
Active Insiders
2
last 12 mo
Over the past 12 months, insider activity at Anika Therapeutics, Inc. (ANIK) has been exclusively buying, with 2 insider purchases totaling $223.2K and 0 insider sales totaling $0.00. The most recent insider transaction was by HENNEMAN JOHN B III (director), who purchased $73.3K worth of shares on May 4, 2026. Anika Therapeutics, Inc. operates in the Healthcare sector, within the Medical - Devices industry, with a market cap of $215.7M.
ANIK Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| May 4, 2026 | HENNEMAN JOHN B III | director | Buy | 5,000 | $14.66 | $73.3K | 54,871 |
| Apr 30, 2026 | Griffin Stephen D. | director, officer: President and CEO | Buy | 12,200 | $12.29 | $149.9K | 36,163+51% |
| Jun 3, 2025 | Griffin Stephen D. | EVP, CFO & COO | Sell | 3,769 | $11.59 | $43.7K | 0 |
| Mar 14, 2025 | Blanchard Cheryl R | President, CEO, Director | Sell | 12,152 | $15.91 | $193.3K | 0 |
| Mar 14, 2025 | Colleran David | EVP, General Counsel, Corp Sec | Sell | 1,893 | $15.91 | $30.1K | 0 |
| Mar 14, 2025 | Nunes Anne | SVP, Chief Operations Officer | Sell | 1,068 | $15.91 | $17.0K | 0 |
| Mar 11, 2025 | Blanchard Cheryl R | President, CEO, Director | Sell | 12,675 | $16.79 | $212.8K | 0 |
| Mar 11, 2025 | Colleran David | EVP, General Counsel, Corp Sec | Sell | 2,250 | $16.79 | $37.8K | 0 |
| Mar 11, 2025 | Nunes Anne | SVP, Chief Operations Officer | Sell | 752 | $16.79 | $12.6K | 0 |
| Mar 10, 2025 | Blanchard Cheryl R | President, CEO, Director | Sell | 5,871 | $16.62 | $97.6K | 0 |
| Mar 10, 2025 | Colleran David | EVP, General Counsel, Corp Sec | Sell | 1,604 | $16.62 | $26.7K | 0 |
| Mar 10, 2025 | Nunes Anne | SVP, Chief Operations Officer | Sell | 959 | $16.62 | $15.9K | 0 |
| Oct 1, 2024 | Nunes Anne | SVP, Chief Operations Officer | Sell | 732 | $24.27 | $17.8K | 0 |
| Mar 11, 2024 | Blanchard Cheryl R | President, CEO, Director | Sell | 27,980 | $25.61 | $716.6K | 0 |
| Mar 11, 2024 | Colleran David | EVP, General Counsel, Corp Sec | Sell | 4,936 | $25.59 | $126.3K | 0 |
| Mar 11, 2024 | Levitz Michael L | EVP, CFO, Treasurer | Sell | 5,638 | $25.59 | $144.3K | 0 |
| Mar 11, 2024 | Nunes Anne | SVP, Chief Operations Officer | Sell | 1,720 | $25.58 | $44.0K | 0 |
| Oct 1, 2023 | Nunes Anne | SVP, Chief Operations Officer | Sell | 732 | $18.63 | $13.6K | 0 |
| Aug 10, 2023 | Levitz Michael L | EVP, CFO, Treasurer | Sell | 1,133 | $18.58 | $21.1K | 0 |
| Apr 26, 2023 | Blanchard Cheryl R | President, CEO, Director | Sell | 10,900 | $26.34 | $287.1K | 0 |
| Mar 10, 2023 | Blanchard Cheryl R | President, CEO, Director | Sell | 13,211 | $26.10 | $344.8K | 0 |
| Mar 10, 2023 | Colleran David | EVP, General Counsel, Corp Sec | Sell | 2,250 | $26.10 | $58.7K | 0 |
| Mar 10, 2023 | Levitz Michael L | EVP, CFO, Treasurer | Sell | 2,609 | $26.10 | $68.1K | 0 |
| Mar 9, 2023 | Blanchard Cheryl R | President, CEO, Director | Sell | 4,232 | $26.91 | $113.9K | 0 |
| Mar 9, 2023 | Colleran David | EVP, General Counsel, Corp Sec | Sell | 1,081 | $26.91 | $29.1K | 0 |
| Mar 9, 2023 | Levitz Michael L | EVP, CFO, Treasurer | Sell | 1,303 | $26.91 | $35.1K | 0 |
| Mar 4, 2023 | Colleran David | EVP, General Counsel, Corp Sec | Sell | 734 | $31.59 | $23.2K | 0 |
| May 11, 2022 | Colleran David | EVP, General Counsel, Corp Sec | Buy | 1,500 | $21.37 | $32.1K | 0 |
| Mar 14, 2022 | Colleran David | EVP, General Counsel, Corp Sec | Buy | 1,500 | $26.65 | $40.0K | 0 |
| Mar 11, 2022 | Blanchard Cheryl R | President, CEO, Director | Buy | 8,100 | $25.57 | $207.1K | 0 |
| Mar 11, 2022 | Levitz Michael L | EVP, CFO, Treasurer | Buy | 4,000 | $24.62 | $98.5K | 0 |
| Mar 11, 2022 | Thompson Jeffery S | Director | Buy | 2,000 | $24.66 | $49.3K | 0 |
| Mar 9, 2022 | Colleran David | EVP, General Counsel, Corp Sec | Sell | 1,081 | $26.22 | $28.3K | 0 |
| Mar 9, 2022 | Finnerty Thomas | EVP, Human Resources | Sell | 748 | $26.22 | $19.6K | 0 |
| Mar 4, 2022 | Colleran David | EVP, General Counsel, Corp Sec | Sell | 734 | $31.06 | $22.8K | 0 |
| Feb 25, 2022 | Finnerty Thomas | EVP, Human Resources | Sell | 1,713 | $32.13 | $55.0K | 0 |
| Feb 9, 2022 | Finnerty Thomas | EVP, Human Resources | Sell | 3,149 | $30.72 | $96.7K | 0 |
| Aug 11, 2021 | Levitz Michael L | EVP, CFO, Treasurer | Buy | 3,627 | $40.21 | $145.8K | 0 |
| Jul 8, 2021 | Loerop James | EVP Business Development | Sell | 731 | $43.24 | $31.6K | 0 |
| May 18, 2021 | HENNEMAN JOHN B III | Director | Buy | 2,000 | $42.86 | $85.7K | 0 |
| May 12, 2021 | LAND RAYMOND J | Director | Sell | 2,000 | $42.60 | $85.2K | 0 |
| Feb 25, 2021 | Finnerty Thomas | EVP Human Resources | Sell | 1,713 | $37.48 | $64.2K | 0 |
ANIK Insider Buying Activity
The following table shows recent insider purchases of Anika Therapeutics, Inc. (ANIK) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| May 4, 2026 | HENNEMAN JOHN B III | director | Buy | 5,000 | $14.66 | $73.3K | 54,871 |
| Apr 30, 2026 | Griffin Stephen D. | director, officer: President and CEO | Buy | 12,200 | $12.29 | $149.9K | 36,163+51% |
| May 11, 2022 | Colleran David | EVP, General Counsel, Corp Sec | Buy | 1,500 | $21.37 | $32.1K | 0 |
| Mar 14, 2022 | Colleran David | EVP, General Counsel, Corp Sec | Buy | 1,500 | $26.65 | $40.0K | 0 |
| Mar 11, 2022 | Blanchard Cheryl R | President, CEO, Director | Buy | 8,100 | $25.57 | $207.1K | 0 |
| Mar 11, 2022 | Levitz Michael L | EVP, CFO, Treasurer | Buy | 4,000 | $24.62 | $98.5K | 0 |
| Mar 11, 2022 | Thompson Jeffery S | Director | Buy | 2,000 | $24.66 | $49.3K | 0 |
| Aug 11, 2021 | Levitz Michael L | EVP, CFO, Treasurer | Buy | 3,627 | $40.21 | $145.8K | 0 |
| May 18, 2021 | HENNEMAN JOHN B III | Director | Buy | 2,000 | $42.86 | $85.7K | 0 |
ANIK Insider Selling Activity
The following table shows recent insider sales of Anika Therapeutics, Inc. (ANIK) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jun 3, 2025 | Griffin Stephen D. | EVP, CFO & COO | Sell | 3,769 | $11.59 | $43.7K | 0 |
| Mar 14, 2025 | Blanchard Cheryl R | President, CEO, Director | Sell | 12,152 | $15.91 | $193.3K | 0 |
| Mar 14, 2025 | Colleran David | EVP, General Counsel, Corp Sec | Sell | 1,893 | $15.91 | $30.1K | 0 |
| Mar 14, 2025 | Nunes Anne | SVP, Chief Operations Officer | Sell | 1,068 | $15.91 | $17.0K | 0 |
| Mar 11, 2025 | Blanchard Cheryl R | President, CEO, Director | Sell | 12,675 | $16.79 | $212.8K | 0 |
| Mar 11, 2025 | Colleran David | EVP, General Counsel, Corp Sec | Sell | 2,250 | $16.79 | $37.8K | 0 |
| Mar 11, 2025 | Nunes Anne | SVP, Chief Operations Officer | Sell | 752 | $16.79 | $12.6K | 0 |
| Mar 10, 2025 | Blanchard Cheryl R | President, CEO, Director | Sell | 5,871 | $16.62 | $97.6K | 0 |
| Mar 10, 2025 | Colleran David | EVP, General Counsel, Corp Sec | Sell | 1,604 | $16.62 | $26.7K | 0 |
| Mar 10, 2025 | Nunes Anne | SVP, Chief Operations Officer | Sell | 959 | $16.62 | $15.9K | 0 |
| Oct 1, 2024 | Nunes Anne | SVP, Chief Operations Officer | Sell | 732 | $24.27 | $17.8K | 0 |
| Mar 11, 2024 | Blanchard Cheryl R | President, CEO, Director | Sell | 27,980 | $25.61 | $716.6K | 0 |
| Mar 11, 2024 | Colleran David | EVP, General Counsel, Corp Sec | Sell | 4,936 | $25.59 | $126.3K | 0 |
| Mar 11, 2024 | Levitz Michael L | EVP, CFO, Treasurer | Sell | 5,638 | $25.59 | $144.3K | 0 |
| Mar 11, 2024 | Nunes Anne | SVP, Chief Operations Officer | Sell | 1,720 | $25.58 | $44.0K | 0 |
| Oct 1, 2023 | Nunes Anne | SVP, Chief Operations Officer | Sell | 732 | $18.63 | $13.6K | 0 |
| Aug 10, 2023 | Levitz Michael L | EVP, CFO, Treasurer | Sell | 1,133 | $18.58 | $21.1K | 0 |
| Apr 26, 2023 | Blanchard Cheryl R | President, CEO, Director | Sell | 10,900 | $26.34 | $287.1K | 0 |
| Mar 10, 2023 | Blanchard Cheryl R | President, CEO, Director | Sell | 13,211 | $26.10 | $344.8K | 0 |
| Mar 10, 2023 | Colleran David | EVP, General Counsel, Corp Sec | Sell | 2,250 | $26.10 | $58.7K | 0 |
| Mar 10, 2023 | Levitz Michael L | EVP, CFO, Treasurer | Sell | 2,609 | $26.10 | $68.1K | 0 |
| Mar 9, 2023 | Blanchard Cheryl R | President, CEO, Director | Sell | 4,232 | $26.91 | $113.9K | 0 |
| Mar 9, 2023 | Colleran David | EVP, General Counsel, Corp Sec | Sell | 1,081 | $26.91 | $29.1K | 0 |
| Mar 9, 2023 | Levitz Michael L | EVP, CFO, Treasurer | Sell | 1,303 | $26.91 | $35.1K | 0 |
| Mar 4, 2023 | Colleran David | EVP, General Counsel, Corp Sec | Sell | 734 | $31.59 | $23.2K | 0 |
| Mar 9, 2022 | Colleran David | EVP, General Counsel, Corp Sec | Sell | 1,081 | $26.22 | $28.3K | 0 |
| Mar 9, 2022 | Finnerty Thomas | EVP, Human Resources | Sell | 748 | $26.22 | $19.6K | 0 |
| Mar 4, 2022 | Colleran David | EVP, General Counsel, Corp Sec | Sell | 734 | $31.06 | $22.8K | 0 |
| Feb 25, 2022 | Finnerty Thomas | EVP, Human Resources | Sell | 1,713 | $32.13 | $55.0K | 0 |
| Feb 9, 2022 | Finnerty Thomas | EVP, Human Resources | Sell | 3,149 | $30.72 | $96.7K | 0 |
| Jul 8, 2021 | Loerop James | EVP Business Development | Sell | 731 | $43.24 | $31.6K | 0 |
| May 12, 2021 | LAND RAYMOND J | Director | Sell | 2,000 | $42.60 | $85.2K | 0 |
| Feb 25, 2021 | Finnerty Thomas | EVP Human Resources | Sell | 1,713 | $37.48 | $64.2K | 0 |
ANIK Insiders
Similar Stocks to ANIK
ISRG
Intuitive Surgical, Inc.
$410.38-0.59%
$149.48B
SYK
Stryker Corporation
$311.49+1.97%
$117.18B
BSX
Boston Scientific Corporation
$46.98-0.38%
$72.16B
EW
Edwards Lifesciences Corporation
$84.90-0.98%
$49.50B
DXCM
DexCom, Inc.
$75.26+0.07%
$29.57B
RMD
ResMed Inc.
$193.86+0.75%
$28.44B
ZBH
Zimmer Biomet Holdings, Inc.
$88.54+1.61%
$16.88B
PEN
Penumbra, Inc.
$318.44+0.04%
$12.59B